Cargando…
Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include...
Autores principales: | Yu, Baozhong, Zhang, Jiandong, Sun, Zejia, Cao, Peng, Zheng, Xiang, Gao, Zihao, Cao, Haoyuan, Zhang, Feilong, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/ https://www.ncbi.nlm.nih.gov/pubmed/33429832 http://dx.doi.org/10.1097/MD.0000000000024257 |
Ejemplares similares
-
Nephrogenic adenoma of the renal pelvis: A rare case report and review of the literature
por: Zhang, Feilong, et al.
Publicado: (2021) -
The safety and efficacy of doxazosin in medical expulsion therapy for distal ureteric calculi: A meta-analysis
por: Yu, Baozhong, et al.
Publicado: (2021) -
IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
por: Yu, Baozhong, et al.
Publicado: (2021) -
Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor
por: Wang, Haoyuan, et al.
Publicado: (2023) -
Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis
por: Ma, Zhifang, et al.
Publicado: (2020)